Antibodies to human tumor necrosis factor receptor TR9

Details Antibodies to human tumor necrosis factor receptor TR9 Antibodies to human tumor necrosis factor receptor TR9

2005-07-19

2005-07-19

Spector, Lorraine (Department: 1646)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Binds antigen or epitope whose amino acid sequence is...

C424S178100, C530S350000, C530S387900, C530S388220, C530S389100, C530S388150, C530S387300, C530S391700, C530S391300, C530S391100, C435S007210, C435S334000, C435S328000, C436S501000

Reexamination Certificate

active

06919078

ABSTRACT:
The present invention relates to a novel member of the tumor necrosis factor family of receptors. In particular, isolated nucleic acid molecules are provided encoding the human TR9 receptor. TR9 polypeptides are also provided as are antibodies, vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TR9 receptor activity.

REFERENCES:
patent: 5112954 (1992-05-01), Abrams et al.
patent: 5563039 (1996-10-01), Goeddel et al.
patent: 5856161 (1999-01-01), Aggarwal et al.
patent: 5876691 (1999-03-01), Chester et al.
patent: 6013476 (2000-01-01), Deen et al.
patent: 6235883 (2001-05-01), Jakobovits et al.
patent: 198 18 619 (1999-10-01), None
patent: 0869179 (1998-10-01), None
patent: WO 98/45437 (1998-10-01), None
patent: WO 98/56892 (1998-12-01), None
patent: WO 99/11790 (1999-03-01), None
patent: WO 99/15663 (1999-04-01), None
patent: WO 99/31128 (1999-06-01), None
patent: WO 99/46281 (1999-09-01), None
patent: WO 99/66039 (1999-12-01), None
patent: WO 00/01817 (2000-01-01), None
patent: WO 00/24771 (2000-05-01), None
patent: WO 00/34294 (2000-06-01), None
patent: WO 00/34335 (2000-06-01), None
patent: WO 00/37643 (2000-06-01), None
patent: WO 00/53756 (2000-09-01), None
GenBank Accession No. AAC34583 (Sep. 5, 1998).
GenBank Accession No. AF068868 (Sep. 5, 1998).
GenBank Accession No. AL096801 (Nov. 29, 1999).
GenBank Accession No. AA156356 (Dec. 11, 1996).
GenBank Accession No. N49208 (Feb. 14, 1996).
GenBank Accession No. AA351536 (Apr. 21, 1997).
GenBank Accession No. AA155873 (Dec. 11, 1996).
GenBank Accession No. D59902 (Aug. 28, 1995).
GenBank Accession No. H41872 (Jul. 31, 1995).
GenBank Accession No. AA357231 (Apr. 21, 1997).
GenBank Accession No. H41873 (Jul. 31, 1995).
GenBank Accession No. T17352 (Feb. 14, 1997).
GenBank Accession No. AA374471 (Apr. 21, 1997).
Pan et al.,Identification and functional characterization of DR6, a novel death domain-containing TNF receptor,FEBS Letters, 431:351-356 (1998).
Yoshimatsu et al.,Control of Gene Expression by Artificial Introns in Saccharomyces cerevisiae,Science, 244:1346-1348.
EMBL Accession No. S50578 (12-XX-94).
GenBank Accession No. AA918818 (Apr 13, 1998).
GenBank Accession No. AA186423 (Jan 6, 1997).
GenBank Accession No. AA072902 (Oct 1, 1996).
GeneSeq (Version 67.0) Abstract of German Document DE19818619 (Aug 7, 2001).
U.S. Appl. No. 60/041,796, Hurle.

Affiliated with

Also associated with

Rating

Antibodies to human tumor necrosis factor receptor TR9 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to human tumor necrosis factor receptor TR9, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to human tumor necrosis factor receptor TR9 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3385676